Table 1.
Open in new tab

Antimicrobial susceptibility interpretive criteria

Antimicrobial agentMIC interpretive criteria (mg/L)
susceptibleintermediateresistant
Ticarcillin/clavulanate≤16/232/2–64/2≥128/2
Ceftazidime≤816≥32
Minocycline≤48≥16
Levofloxacin≤24≥8
Trimethoprim/sulfamethoxazole≤2/38—≥4/76
Moxifloxacin≤24≥8
Cefepime≤816≥32
Antimicrobial agentMIC interpretive criteria (mg/L)
susceptibleintermediateresistant
Ticarcillin/clavulanate≤16/232/2–64/2≥128/2
Ceftazidime≤816≥32
Minocycline≤48≥16
Levofloxacin≤24≥8
Trimethoprim/sulfamethoxazole≤2/38—≥4/76
Moxifloxacin≤24≥8
Cefepime≤816≥32
Table 1.
Open in new tab

Antimicrobial susceptibility interpretive criteria

Antimicrobial agentMIC interpretive criteria (mg/L)
susceptibleintermediateresistant
Ticarcillin/clavulanate≤16/232/2–64/2≥128/2
Ceftazidime≤816≥32
Minocycline≤48≥16
Levofloxacin≤24≥8
Trimethoprim/sulfamethoxazole≤2/38—≥4/76
Moxifloxacin≤24≥8
Cefepime≤816≥32
Antimicrobial agentMIC interpretive criteria (mg/L)
susceptibleintermediateresistant
Ticarcillin/clavulanate≤16/232/2–64/2≥128/2
Ceftazidime≤816≥32
Minocycline≤48≥16
Levofloxacin≤24≥8
Trimethoprim/sulfamethoxazole≤2/38—≥4/76
Moxifloxacin≤24≥8
Cefepime≤816≥32
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close